New osteoporosis drug combination outperforms current alternatives
A combination of two FDA-approved osteoporosis drugs with different mechanisms of action was found to increase bone density better than treatment with either drug alone in a small clinical trial. As reported in paper receiving ...
May 14, 2013
0
0